Is Spire Healthcare Group plc a good investment? Spire Healthcare Group plc (SPI.L) is currently trading at 247.00 GBX. Market analysts have a consensus price target of 264.25 GBX. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 61.38. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Spire Healthcare Group plc is expected to release its next earnings report on March 4, 2027. The market consensus estimate for Forward EPS is 0.17.
For income investors, Spire Healthcare Group plc pays a dividend yield of 0.61%. With a payout ratio of 56%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.02 GBX (0.61% yield).
Spire Healthcare Group plc is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be March 4, 2027. The company currently has a trailing EPS of 0.04.
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
| Year | Total Dividends |
|---|---|
| ▸2027 |
1.50 GBX
|
| June 25, 2027 (estimated) | 1.5000 |
| ▸2026 |
1.50 GBX
|
| June 19, 2026 | 1.5000 |
| ▸2025 |
2.30 GBX
|
| June 20, 2025 | 2.3000 |
| ▸2024 |
2.10 GBX
|
| June 21, 2024 | 2.1000 |
| ▸2023 |
0.50 GBX
|
| June 23, 2023 | 0.5000 |
| ▸2019 |
2.84 GBX
|
| Dec. 10, 2019 | 0.9710 |
| June 25, 2019 | 1.8672 |
| ▸2018 |
2.84 GBX
|
| Dec. 11, 2018 | 0.9710 |
| June 26, 2018 | 1.8672 |
| ▸2017 |
2.84 GBX
|
| Dec. 12, 2017 | 0.9710 |
| June 27, 2017 | 1.8672 |
| ▸2016 |
2.76 GBX
|
| Dec. 13, 2016 | 0.9710 |
| June 28, 2016 | 1.7925 |
| ▸2015 |
2.32 GBX
|
| Dec. 15, 2015 | 0.9710 |
| June 30, 2015 | 1.3444 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Spire Healthcare Group plc | Jun 19, 2026 | Paid | 1.5 GBX |
Community Discussion